STOCK TITAN

STRM merger: $5.34 cash per share; Form 4 shows restricted award cash-out

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Wendy L. Lovvorn, Chief People Officer, reported changes in her ownership of Streamline Health Solutions, Inc. (STRM) tied to a completed merger. The Form 4 discloses that the Merger Agreement dated May 29, 2025, became effective August 12, 2025, when Merger Sub merged into the issuer and the issuer became a wholly owned subsidiary of Mist Holding Co. At the Effective Time, each outstanding share of common stock was canceled and converted into the right to receive $5.34 in cash per share.

The filing notes that 11,686 restricted shares were included in the cash conversion (paid net of withholding taxes) and that the reporting person’s beneficial ownership following the reported transaction was 27,216 shares (direct). The Form 4 therefore documents a cash-out of both vested and unvested awards under the merger terms and confirms the company’s change-of-control outcome.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Completed change-of-control merger converted common stock to $5.34 cash per share; this is a material corporate transaction.

The Form 4 confirms the Merger Agreement closed, with the issuer surviving as a wholly owned subsidiary of Mist Holding Co. All outstanding common shares were canceled and converted into the stated cash consideration of $5.34 per share. The filing explicitly treats unvested restricted awards as cash-out items, and quantifies 11,686 restricted shares included. These facts represent a definitive liquidity event for equity holders and a full transfer of control.

TL;DR: Insider disclosure documents disposition under merger and the cash-out treatment of restricted awards, confirming governance consequences.

The reporting person, identified as the Chief People Officer, reported dispositions pursuant to the Merger Agreement and the Effective Time mechanics. The Form 4 clearly states that awards tied to common stock were canceled and converted into cash less applicable withholding taxes, and it records the reporter’s remaining direct beneficial ownership of 27,216 shares. This filing provides transparent documentation of insider treatment under the transaction and the post-closing ownership snapshot.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lovvorn Wendy L

(Last) (First) (Middle)
2400 OLD MILTON PARKWAY
BOX 1353

(Street)
ALPHARETTA GA 30009

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STREAMLINE HEALTH SOLUTIONS INC. [ STRM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief People Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.01 par value 08/12/2025 D(1) 27,216(2) D (1)(2) 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2025, by and among the Issuer, Mist Holding Co. ("Parent"), and MD BE Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer, effective as of August 12, 2025, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock, par value $0.01 per share, of the Company ("Common Stock") issued and outstanding as of immediately prior to the Effective Time was canceled and converted into the right to receive $5.34 in cash, without interest (the "Merger Consideration").
2. Includes 11,686 shares of restricted stock. Pursuant to the terms of the Merger Agreement, at the Effective Time, each restricted stock award corresponding to shares of Common Stock that was outstanding and unvested as of immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of Common Stock corresponding to such award of restricted stock immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration, less applicable withholding taxes.
/s/ Wendy L Lovvorn 08/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Streamline Health Solutions In

NASDAQ:STRM

STRM Rankings

STRM Latest News

STRM Latest SEC Filings

STRM Stock Data

23.23M
3.60M
17.45%
27.53%
0.33%
Health Information Services
Services-computer Integrated Systems Design
Link
United States
ALPHARETTA